Logo image of AGEN

AGENUS INC (AGEN) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:AGEN - US00847G8042 - Common Stock

4.08 USD
-0.01 (-0.24%)
Last: 12/11/2025, 8:18:54 PM
4.04 USD
-0.04 (-0.98%)
After Hours: 12/11/2025, 8:18:54 PM
Fundamental Rating

1

Taking everything into account, AGEN scores 1 out of 10 in our fundamental rating. AGEN was compared to 531 industry peers in the Biotechnology industry. Both the profitability and financial health of AGEN have multiple concerns. AGEN is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year AGEN has reported negative net income.
In the past year AGEN has reported a negative cash flow from operations.
AGEN had negative earnings in each of the past 5 years.
In the past 5 years AGEN reported 4 times negative operating cash flow.
AGEN Yearly Net Income VS EBIT VS OCF VS FCFAGEN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50M -100M -150M -200M

1.2 Ratios

The Return On Assets of AGEN (-15.13%) is better than 79.85% of its industry peers.
Industry RankSector Rank
ROA -15.13%
ROE N/A
ROIC N/A
ROA(3y)-77.38%
ROA(5y)-64.35%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AGEN Yearly ROA, ROE, ROICAGEN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K

1.3 Margins

Looking at the Gross Margin, with a value of 98.93%, AGEN belongs to the top of the industry, outperforming 98.12% of the companies in the same industry.
AGEN's Gross Margin has been stable in the last couple of years.
AGEN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 98.93%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.24%
GM growth 5YN/A
AGEN Yearly Profit, Operating, Gross MarginsAGEN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400

More info and screens

0

2. Health

2.1 Basic Checks

AGEN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, AGEN has more shares outstanding
Compared to 5 years ago, AGEN has more shares outstanding
Compared to 1 year ago, AGEN has a worse debt to assets ratio.
AGEN Yearly Shares OutstandingAGEN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
AGEN Yearly Total Debt VS Total AssetsAGEN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

AGEN has an Altman-Z score of -14.06. This is a bad value and indicates that AGEN is not financially healthy and even has some risk of bankruptcy.
AGEN has a worse Altman-Z score (-14.06) than 78.72% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -14.06
ROIC/WACCN/A
WACC6.07%
AGEN Yearly LT Debt VS Equity VS FCFAGEN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M -300M

2.3 Liquidity

AGEN has a Current Ratio of 0.47. This is a bad value and indicates that AGEN is not financially healthy enough and could expect problems in meeting its short term obligations.
AGEN's Current ratio of 0.47 is on the low side compared to the rest of the industry. AGEN is outperformed by 92.66% of its industry peers.
AGEN has a Quick Ratio of 0.47. This is a bad value and indicates that AGEN is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.47, AGEN is not doing good in the industry: 92.09% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.47
Quick Ratio 0.47
AGEN Yearly Current Assets VS Current LiabilitesAGEN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 81.05% over the past year.
The Revenue for AGEN has decreased by -33.41% in the past year. This is quite bad
The Revenue has been decreasing by -7.17% on average over the past years.
EPS 1Y (TTM)81.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%162.99%
Revenue 1Y (TTM)-33.41%
Revenue growth 3Y-29.53%
Revenue growth 5Y-7.17%
Sales Q2Q%20.4%

3.2 Future

Based on estimates for the next years, AGEN will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.77% on average per year.
AGEN is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 16.37% yearly.
EPS Next Y109.04%
EPS Next 2Y40.26%
EPS Next 3Y21.83%
EPS Next 5Y14.77%
Revenue Next Year59.32%
Revenue Next 2Y7.44%
Revenue Next 3Y4.37%
Revenue Next 5Y16.37%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
AGEN Yearly Revenue VS EstimatesAGEN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 100M 200M 300M
AGEN Yearly EPS VS EstimatesAGEN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 -10 -20

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AGEN. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AGEN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AGEN Price Earnings VS Forward Price EarningsAGEN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AGEN Per share dataAGEN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 -4 -6 -8

4.3 Compensation for Growth

AGEN's earnings are expected to grow with 21.83% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.26%
EPS Next 3Y21.83%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for AGEN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AGENUS INC

NASDAQ:AGEN (12/11/2025, 8:18:54 PM)

After market: 4.04 -0.04 (-0.98%)

4.08

-0.01 (-0.24%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-10 2025-11-10/bmo
Earnings (Next)03-09 2026-03-09/amc
Inst Owners29.26%
Inst Owner Change-0.92%
Ins Owners1.67%
Ins Owner Change0.29%
Market Cap138.76M
Revenue(TTM)106.83M
Net Income(TTM)-35.38M
Analysts80
Price Target12.58 (208.33%)
Short Float %5.35%
Short Ratio3.76
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-88.19%
Min EPS beat(2)-172.44%
Max EPS beat(2)-3.94%
EPS beat(4)2
Avg EPS beat(4)-29.02%
Min EPS beat(4)-172.44%
Max EPS beat(4)38.98%
EPS beat(8)3
Avg EPS beat(8)-44.03%
EPS beat(12)5
Avg EPS beat(12)-28.61%
EPS beat(16)8
Avg EPS beat(16)-21.22%
Revenue beat(2)0
Avg Revenue beat(2)-48.06%
Min Revenue beat(2)-49.33%
Max Revenue beat(2)-46.8%
Revenue beat(4)0
Avg Revenue beat(4)-29.94%
Min Revenue beat(4)-49.33%
Max Revenue beat(4)-10.55%
Revenue beat(8)1
Avg Revenue beat(8)-20.83%
Revenue beat(12)3
Avg Revenue beat(12)-9.34%
Revenue beat(16)6
Avg Revenue beat(16)-1.64%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)16.47%
EPS NQ rev (3m)16.47%
EPS NY rev (1m)-19.77%
EPS NY rev (3m)323.89%
Revenue NQ rev (1m)40.55%
Revenue NQ rev (3m)170.55%
Revenue NY rev (1m)4.15%
Revenue NY rev (3m)32.4%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.3
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-2.13
EYN/A
EPS(NY)-0.35
Fwd EYN/A
FCF(TTM)-2.63
FCFYN/A
OCF(TTM)-2.62
OCFYN/A
SpS3.14
BVpS-8.06
TBVpS-8.86
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -15.13%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 98.93%
FCFM N/A
ROA(3y)-77.38%
ROA(5y)-64.35%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.24%
GM growth 5YN/A
F-Score2
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0.62%
Cap/Sales 0.07%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.47
Quick Ratio 0.47
Altman-Z -14.06
F-Score2
WACC6.07%
ROIC/WACCN/A
Cap/Depr(3y)280.5%
Cap/Depr(5y)277.58%
Cap/Sales(3y)20.35%
Cap/Sales(5y)15.28%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)81.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%162.99%
EPS Next Y109.04%
EPS Next 2Y40.26%
EPS Next 3Y21.83%
EPS Next 5Y14.77%
Revenue 1Y (TTM)-33.41%
Revenue growth 3Y-29.53%
Revenue growth 5Y-7.17%
Sales Q2Q%20.4%
Revenue Next Year59.32%
Revenue Next 2Y7.44%
Revenue Next 3Y4.37%
Revenue Next 5Y16.37%
EBIT growth 1Y37.56%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-7.17%
EBIT Next 3Y-10.15%
EBIT Next 5Y-10.98%
FCF growth 1Y65.01%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y61.4%
OCF growth 3YN/A
OCF growth 5YN/A

AGENUS INC / AGEN FAQ

Can you provide the ChartMill fundamental rating for AGENUS INC?

ChartMill assigns a fundamental rating of 1 / 10 to AGEN.


What is the valuation status for AGEN stock?

ChartMill assigns a valuation rating of 1 / 10 to AGENUS INC (AGEN). This can be considered as Overvalued.


What is the profitability of AGEN stock?

AGENUS INC (AGEN) has a profitability rating of 2 / 10.


Can you provide the financial health for AGEN stock?

The financial health rating of AGENUS INC (AGEN) is 0 / 10.